A novel life cycle modeling system for Ebola virus shows a genome length-dependent role of VP24 in virus infectivity

Journal of Virology

Volumn 88, Issue 18, 2014, Pages 10511-10524

  Watt, Ari ^a   Moukambi, Felicien ^b,c   Banadyga, Logan ^a   Groseth, Allison ^a,b   Callison, Julie ^a   Herwig, Astrid ^b   Ebihara, Hideki ^a   Feldmann, Heinz ^a   Hoenen, Thomas ^a,b  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

^c LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DIHYDROLIPOAMIDE DEHYDROGENASE; FIREFLY LUCIFERASE; GP1,2 PROTEIN; KIDNEY INJURY MOLECULE 1; NP PROTEIN; PROTEIN VP40; RENILLA LUCIFERIN 2 MONOOXYGENASE; UNCLASSIFIED DRUG; VIRUS PROTEIN; VP24 PROTEIN; VP30 PROTEIN; VP35 PROTEIN; VP24 PROTEIN, EBOLA VIRUS;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; EBOLA VIRUS; EMBRYO; ENZYME ACTIVITY; GENE EXPRESSION; GENE REPLICATION; GENETIC REGULATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; LIFE CYCLE MODELING SYSTEM; MODEL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; VIRUS ASSEMBLY; VIRUS GENOME; VIRUS INFECTIVITY; VIRUS LIKE AGENT; VIRUS NUCLEOCAPSID; EBOLA HEMORRHAGIC FEVER; GENETICS; GROWTH, DEVELOPMENT AND AGING; METABOLISM; PATHOGENICITY; PHYSIOLOGY; VIROLOGY; VIRULENCE; VIRUS REPLICATION;

EBOLAVIRUS; GENOME, VIRAL; HEMORRHAGIC FEVER, EBOLA; HUMANS; VIRAL PROTEINS; VIRULENCE; VIRUS ASSEMBLY; VIRUS REPLICATION;

EID: 84906342319     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01272-14     Document Type: Article

References (45)

1. Feldmann H, Geisbert TW. 2011. Ebola haemorrhagic fever. Lancet 377:849-862. http://dx.doi.org/10.1016/S0140-6736(10)60667-8.
2. Reid SP, Leung LW, Hartman AL, Martinez O, Shaw ML, Carbonnelle C, Volchkov VE, Nichol ST, Basler CF. 2006. Ebola virus VP24 binds karyopherin alpha1 and blocks STAT1 nuclear accumulation. J. Virol. 80:5156-5167. http://dx.doi.org/10.1128/JVI.02349-05.
3. Halfmann P, Neumann G, Kawaoka Y. 2011. The Ebolavirus VP24 protein blocks phosphorylation of p38 mitogen-activated protein kinase. J. Infect. Dis. 204(Suppl 3):S953-S956. http://dx.doi.org/10.1093/infdis/jir325.
4. Mateo M, Reid SP, Leung LW, Basler CF, Volchkov VE. 2010. Ebolavirus VP24 binding to karyopherins is required for inhibition of interferon signaling. J. Virol. 84:1169-1175. http://dx.doi.org/10.1128/JVI.01372-09.
5. Shabman RS, Gulcicek EE, Stone KL, Basler CF. 2011. The Ebola virus VP24 protein prevents hnRNP C1/C2 binding to karyopherin alpha1 andpartially alters its nuclear import. J. Infect. Dis. 204(Suppl 3):S904-S910. http://dx.doi.org/10.1093/infdis/jir323.
6. Zhang AP, Bornholdt ZA, Liu T, Abelson DM, Lee DE, Li S, Woods VL, Jr, Saphire EO. 2012. The Ebola virus interferon antagonist VP24 directly binds STAT1 and has a novel, pyramidal fold. PLoS Pathog. 8:e1002550. http://dx.doi.org/10.1371/journal.ppat.1002550.
7. Reid SP, Valmas C, Martinez O, Sanchez FM, Basler CF. 2007. Ebola virus VP24 proteins inhibit the interaction of NPI-1 subfamily karyopherin alpha proteins with activated STAT1. J. Virol. 81:13469- 13477. http://dx.doi.org/10.1128/JVI.01097-07.
8. Halfmann P, Kim JH, Ebihara H, Noda T, Neumann G, Feldmann H, Kawaoka Y. 2008. Generation of biologically contained Ebola viruses. Proc. Natl. Acad. Sci. U. S. A. 105:1129-1133. http://dx.doi.org/10.1073/pnas.0708057105.
9. Hoenen T, Groseth A, de Kok-Mercado F, Kuhn JH, Wahl-Jensen V. 2011. Minigenomes, transcription and replication competent virus-like particles and beyond: reverse genetics systems for filoviruses and other negative stranded hemorrhagic fever viruses. Antiviral Res. 91:195-208. http://dx.doi.org/10.1016/j.antiviral.2011.06.003.
10. Muhlberger E, Weik M, Volchkov VE, Klenk HD, Becker S. 1999. Comparison of the transcription and replication strategies of Marburg virus and Ebola virus by using artificial replication systems. J. Virol. 73: 2333-2342.
11. Hoenen T, Groseth A, Kolesnikova L, Theriault S, Ebihara H, Hartlieb B, Bamberg S, Feldmann H, Stroher U, Becker S. 2006. Infection of naive target cells with virus-like particles: implications for the function of Ebola virus VP24. J. Virol. 80:7260-7264. http://dx.doi.org/10.1128/JVI.00051-06.
12. Watanabe S, Watanabe T, Noda T, Takada A, Feldmann H, Jasenosky LD, Kawaoka Y. 2004. Production of novel Ebola virus-like particles from cDNAs: an alternative to Ebola virus generation by reverse genetics. J. Virol. 78:999-1005. http://dx.doi.org/10.1128/JVI.78.2.999-1005.2004.
13. Noda T, Sagara H, Suzuki E, Takada A, Kida H, Kawaoka Y. 2002. Ebola virus VP40 drives the formation of virus-like filamentous particles along with GP. J. Virol. 76:4855-4865. http://dx.doi.org/10.1128/JVI.76.10.4855-4865.2002
14. Spiegelberg L, Wahl-Jensen V, Kolesnikova L, Feldmann H, Becker S, Hoenen T. 2011. Genus-specific recruitment of filovirus ribonucleoprotein complexes into budding particles. J. Gen. Virol. 92:2900-2905. http://dx.doi.org/10.1099/vir.0.036863-0
15. Hoenen T, Groseth A, Callison J, Takada A, Feldmann H. 2013. A novel Ebola virus expressing luciferase allows for rapid and quantitative testing of antivirals. Antiviral Res. 99:207-213. http://dx.doi.org/10.1016/j.antiviral.2013.05.017
16. Hoenen T, Shabman RS, Groseth A, Herwig A, Weber M, Schudt G, Dolnik O, Basler CF, Becker S, Feldmann H. 2012. Inclusion bodies are a site of ebolavirus replication. J. Virol. 86:11779-11788. http://dx.doi.org/10.1128/JVI.01525-12
17. Shabman RS, Hoenen T, Groseth A, Jabado O, Binning JM, Amarasinghe GK, Feldmann H, Basler CF. 2013. An upstream open reading frame modulates Ebola virus polymerase translation and virus replication. PLoS Pathog. 9:e1003147. http://dx.doi.org/10.1371/journal.ppat.1003147.
18. Lagos-Quintana M, Rauhut R, Yalcin A, Meyer J, Lendeckel W, Tuschl T. 2002. Identification of tissue-specific microRNAs from mouse. Curr. Biol. 12:735-739. http://dx.doi.org/10.1016/S0960-9822(02)00809-6.
19. Geisbert TW, Lee AC, Robbins M, Geisbert JB, Honko AN, Sood V, Johnson JC, de Jong S, Tavakoli I, Judge A, Hensley LE, Maclachlan I. 2010. Postexposure protection of non-human primates against a lethal Ebola virus challenge with RNA interference: a proof-of-concept study. Lancet 375: 1896-1905. http://dx.doi.org/10.1016/S0140-6736(10)60357-1.
20. Hoenen T, Volchkov V, Kolesnikova L, Mittler E, Timmins J, Ottmann M, Reynard O, Becker S, Weissenhorn W. 2005. VP40 octamers are essential for Ebola virus replication. J. Virol. 79:1898-1905. http://dx.doi.org/10.1128/JVI.79.3.1898-1905.2005
21. Hoenen T, Jung S, Herwig A, Groseth A, Becker S. 2010. Both matrix proteins of Ebola virus contribute to the regulation of viral genome replication and transcription. Virology 403:56-66. http://dx.doi.org/10.1016/j.virol.2010.04.002
22. Watanabe S, Noda T, Halfmann P, Jasenosky L, Kawaoka Y. 2007. Ebola virus (EBOV) VP24 inhibits transcription and replication of the EBOV genome. J. Infect. Dis. 196(Suppl 2):S284-S290. http://dx.doi.org/10.1086/520582
23. Nanbo A, Imai M, Watanabe S, Noda T, Takahashi K, Neumann G, Halfmann P, Kawaoka Y. 2010. Ebolavirus is internalized into host cells via macropinocytosis in a viral glycoprotein-dependent manner. PLoS Pathog. 6:e1001121. http://dx.doi.org/10.1371/journal.ppat.1001121.
24. Ebihara H, Theriault S, Neumann G, Alimonti JB, Geisbert JB, Hensley LE, Groseth A, Jones SM, Geisbert TW, Kawaoka Y, Feldmann H. 2007. In vitro and in vivo characterization of recombinant Ebola viruses expressing enhanced green fluorescent protein. J. Infect. Dis. 196(Suppl 2): S313-S322. http://dx.doi.org/10.1086/520590.
25. Kondratowicz AS, Lennemann NJ, Sinn PL, Davey RA, Hunt CL, Moller-Tank S, Meyerholz DK, Rennert P, Mullins RF, Brindley M, Sandersfeld LM, Quinn K, Weller M, McCray PB, Jr, Chiorini J, Maury W. 2011. T-cell immunoglobulin and mucin domain 1 (TIM-1) is a receptor for Zaire Ebolavirus and Lake Victoria Marburgvirus. Proc. Natl. Acad. Sci. U. S. A. 108:8426 - 8431. http://dx.doi.org/10.1073/pnas.1019030108
26. Huang Y, Xu L, Sun Y, Nabel GJ. 2002. The assembly of Ebola virus nucleocapsid requires virion-associated proteins 35 and 24 and posttranslational modification of nucleoprotein. Mol. Cell 10:307-316. http://dx.doi.org/10.1016/S1097-2765(02)00588-9
27. Noda T, Halfmann P, Sagara H, Kawaoka Y. 2007. Regions in Ebola virus VP24 that are important for nucleocapsid formation. J. Infect. Dis. 196(Suppl 2):S247-S250. http://dx.doi.org/10.1086/520596.
28. Beniac DR, Melito PL, Devarennes SL, Hiebert SL, Rabb MJ, Lamboo LL, Jones SM, Booth TF. 2012. The organisation of Ebola virus reveals a capacity for extensive, modular polyploidy. PLoS One 7:e29608. http://dx.doi.org/10.1371/journal.pone.0029608
29. Bharat TA, Noda T, Riches JD, Kraehling V, Kolesnikova L, Becker S, Kawaoka Y, Briggs JA. 2012. Structural dissection of Ebola virus and its assembly determinants using cryo-electron tomography. Proc. Natl. Acad. Sci. U. S. A. 109:4275-4280. http://dx.doi.org/10.1073/pnas.1120453109.
30. Mateo M, Carbonnelle C, Martinez MJ, Reynard O, Page A, Volchkova VA, Volchkov VE. 2011. Knockdown of Ebola virus VP24 impairs viral nucleocapsid assembly and prevents virus replication. J. Infect. Dis. 204(Suppl 3):S892-S896. http://dx.doi.org/10.1093/infdis/jir311.
31. Harty RN, Brown ME, Wang G, Huibregtse J, Hayes FP. 2000. A PPxY motif within the VP40 protein of Ebola virus interacts physically and functionally with a ubiquitin ligase: implications for filovirus budding. Proc. Natl. Acad. Sci. U. S. A. 97:13871-13876. http://dx.doi.org/10.1073/pnas.250277297
32. Timmins J, Scianimanico S, Schoehn G, Weissenhorn W. 2001. Vesicular release of Ebola virus matrix protein VP40. Virology 283:1-6. http://dx.doi.org/10.1006/viro.2001.0860.
33. Wolff S, Ebihara H, Groseth A. 2013. Arenavirus budding: a common pathway with mechanistic differences. Viruses 5:528-549. http://dx.doi.org/10.3390/v5020528
34. Lopez N, Jacamo R, Franze-Fernandez MT. 2001. Transcription and RNA replication of Tacaribe virus genome and antigenome analogs requireNand L proteins: Z protein is an inhibitor of these processes. J. Virol. 75:12241-12251. http://dx.doi.org/10.1128/JVI.75.24.12241-12251.2001.
35. Casabona JC, Levingston Macleod JM, Loureiro ME, Gomez GA, Lopez N. 2009. The RING domain and the L79 residue of Z protein are involved in both the rescue of nucleocapsids and the incorporation of glycoproteins into infectious chimeric arenavirus-like particles. J. Virol. 83:7029-7039. http://dx.doi.org/10.1128/JVI.00329-09.
36. Halpin K, Bankamp B, Harcourt BH, Bellini WJ, Rota PA. 2004. Nipah virus conforms to the rule of six in a minigenome replication assay. J. Gen. Virol. 85:701-707. http://dx.doi.org/10.1099/vir.0.19685-0.
37. Wenigenrath J, Kolesnikova L, Hoenen T, Mittler E, Becker S. 2010. Establishment and application of an infectious virus-like particle system for Marburg virus. J. Gen. Virol. 91:1325-1334. http://dx.doi.org/10.1099/vir.0.018226-0
38. Moller-Tank S, Kondratowicz AS, Davey RA, Rennert PD, Maury W. 2013. Role of the phosphatidylserine receptor TIM-1 in enveloped-virus entry. J. Virol. 87:8327-8341. http://dx.doi.org/10.1128/JVI.01025-13.
39. Carette JE, Raaben M, Wong AC, Herbert AS, Obernosterer G, Mulherkar N, Kuehne AI, Kranzusch PJ, Griffin AM, Ruthel G, Dal Cin P, Dye JM, Whelan SP, Chandran K, Brummelkamp TR. 2011. Ebola virus entry requires the cholesterol transporter Niemann-Pick C1. Nature 477: 340-343. http://dx.doi.org/10.1038/nature10348.
40. Cote M, Misasi J, Ren T, Bruchez A, Lee K, Filone CM, Hensley L, Li Q, Ory D, Chandran K, Cunningham J. 2011. Small molecule inhibitors reveal Niemann-Pick C1 is essential for Ebola virus infection. Nature 477: 344-348. http://dx.doi.org/10.1038/nature10380.
41. Miller EH, Obernosterer G, Raaben M, Herbert AS, Deffieu MS,Krishnan A, Ndungo E, Sandesara RG, Carette JE, Kuehne AI, Ruthel G, Pfeffer SR, Dye JM, Whelan SP, Brummelkamp TR, Chandran K. 2012. Ebola virus entry requires the host-programmed recognition of an intracellular receptor. EMBO J. 31:1947-1960. http://dx.doi.org/10.1038/emboj.2012.53
42. Saeed MF, Kolokoltsov AA, Albrecht T, Davey RA. 2010. Cellular entry of Ebola virus involves uptake by a macropinocytosis-like mechanism and subsequent trafficking through early and late endosomes. PLoS Pathog. 6:e1001110. http://dx.doi.org/10.1371/journal.ppat.1001110.
43. Marzi A, Reinheckel T, Feldmann H. 2012. Cathepsin B & L are not required for Ebola virus replication. PLoS Negl. Trop. Dis. 6:e1923. http://dx.doi.org/10.1371/journal.pntd.0001923
44. Aleksandrowicz P, Marzi A, Biedenkopf N, Beimforde N, Becker S, Hoenen T, Feldmann H, Schnittler HJ. 2011. Ebola virus enters host cells by macropinocytosis and clathrin-mediated endocytosis. J. Infect. Dis. 204(Suppl 3):S957-S967. http://dx.doi.org/10.1093/infdis/jir326.
45. Hoenen T, Biedenkopf N, Zielecki F, Jung S, Groseth A, Feldmann H, Becker S. 2010. Oligomerization of Ebola virus VP40 is essential for particle morphogenesis and regulation of viral transcription. J. Virol. 84: 7053-7063. http://dx.doi.org/10.1128/JVI.00737-10.